-
公开(公告)号:EP4342472A1
公开(公告)日:2024-03-27
申请号:EP22804676.9
申请日:2022-05-17
IPC分类号: A61K31/551 , A61K9/08 , A61P27/10 , C07D239/95
摘要: To provide a new ophthalmic preparation for myopia suppression.
The above-described problem is solved by using an ophthalmic preparation containing bunazosin as an ophthalmic preparation for myopia suppression. This ophthalmic preparation for myopia suppression is effective for myopia suppression.-
公开(公告)号:EP4324463A1
公开(公告)日:2024-02-21
申请号:EP22795016.9
申请日:2022-04-29
发明人: ZHOU, Xiangtian , PAN, Miaozhen , QU, Jia , ZHENG, Qinyuan , WU, Hao
摘要: The present application relates to a method and pharmaceutical composition for treating myopia. The pharmaceutical composition or the method of the present application can effectively prevent and control myopia, is safe and has no obvious side effect, and has a good clinical application prospect.
-
公开(公告)号:EP2849802B1
公开(公告)日:2023-12-20
申请号:EP13791695.3
申请日:2013-05-07
-
公开(公告)号:EP4282402A1
公开(公告)日:2023-11-29
申请号:EP21920749.5
申请日:2021-11-29
发明人: DONG, Qing , XUE, Lubing
IPC分类号: A61K9/08 , A61K9/66 , A61K47/10 , A61K47/26 , A61K47/58 , A61K47/36 , A61K47/38 , A61K31/573 , A61K31/405 , A61P27/02 , A61P27/10
摘要: An ophthalmic preparation for treating macular edema, optic neuritis and non-infectious endophthalmitis. The ophthalmic preparation is a preparation composed of an active ingredient for treating eye diseases and an ophthalmic preparation carrier or auxiliary material; the active ingredient for treating eye diseases is a glucocorticoid medicine and/or a non-steroidal medicine; the ophthalmic preparation carrier or auxiliary material comprises the following ingredients: a surfactant, an ionic polymer and a solvent, or the ophthalmic preparation carrier or auxiliary material contains the following ingredients: povidone with low polymerization degree, povidone with moderate polymerization degree and a solvent. The ophthalmic preparation can carry (wrap) the glucocorticoid and/or the non-steroidal medicines to penetrate through the anterior segment of eyes and be conveyed to the posterior segment of eyes to treat the macular edema, the optic neuritis and the non-infectious endophthalmitis in an eye drop administration mode, and the ophthalmic preparation has extremely excellent clinical use value and positive social significance.
-
公开(公告)号:EP3265096B9
公开(公告)日:2023-10-04
申请号:EP16759200.5
申请日:2016-03-04
发明人: GREEN, Colin , GREENE, Carol Ann , SHERWIN, Trevor
IPC分类号: A61K38/18 , A61K31/573 , A61P27/02 , A61P27/10 , A61P43/00
-
-
公开(公告)号:EP4215190A1
公开(公告)日:2023-07-26
申请号:EP21868601.2
申请日:2021-09-14
发明人: ZHOU, Xiangtian , PAN, Miaozhen , ZHAO, Fei , QU, Jia
摘要: The present invention relates to an application of inhibiting myopia by regulating eye scleral lipid metabolism. The present discloses a new mechanism leading to myopia, i.e., a close relationship between abnormal eye scleral lipid metabolism and myopia, thus revealing a new target for prevention and control of myopia; meanwhile, also provided is an eye drop that can effectively prevent and control myopia while avoiding eye allergies.
-
公开(公告)号:EP4210690A1
公开(公告)日:2023-07-19
申请号:EP21786063.4
申请日:2021-09-03
发明人: NANDURI, Padma , DYER, Aaron
IPC分类号: A61K31/27 , A61K31/407 , A61K31/4178 , A61K31/439 , A61K31/522 , A61P27/10 , A61P27/02 , A61K9/00
-
公开(公告)号:EP4041053A1
公开(公告)日:2022-08-17
申请号:EP20788700.1
申请日:2020-10-12
申请人: Ocuvation Limited
发明人: FLITCROFT, Ian
-
公开(公告)号:EP3849533A1
公开(公告)日:2021-07-21
申请号:EP19860696.4
申请日:2019-09-13
发明人: ASHBY, Regan Scott
IPC分类号: A61K31/137 , A61K31/195 , A61P27/10 , A61P27/02
-
-
-
-
-
-
-
-
-